Key facts
- This page summarizes Elvia Cowan's Form 4 filing for Vaxcyte, Inc. (PCVX).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 02 Sep 2026, 19:54.
Elvia Cowan - 31 Aug 2026 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)
- Reporting relationship
- SVP, Finance & CAO
- Issuer ticker
- PCVX
- Reported as of
- 31 Aug 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Sep 2026, 19:54:51 UTC
- Prior SEC filing
- 08 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- Elvia Cowan, by /s/ Peter N. Efremenko, Attorney-In-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Elvia Cowan filed Form 4 for Vaxcyte, Inc. (PCVX) on 02 Sep 2026.
Change
- Previous filing in this sequence was filed on 08 Apr 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001960048
Primary reporting owner
Cowan Elvia
- Relationship
- SVP, Finance & CAO
- Address
- C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, SUITE 300, SAN CARLOS
- Signature
- Elvia Cowan, by /s/ Peter N. Efremenko, Attorney-In-Fact
- Signature date
- 02 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PCVX
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -243
- Change %
- -0.82%
- Price
- $60.74*
- Shares after
- 29,513
- Date
- 31 Aug 2026
- Ownership
- Direct
- Footnotes
- F1, F2
PCVX
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -326
- Change %
- -1.1%
- Price
- $61.58*
- Shares after
- 29,187
- Date
- 02 Sep 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
Footnote F2
Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.